Aksharchem India Ltd vs Anlon Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of AksharChem (India) Ltd is ₹ 183.05 as of 20 Mar 15:30 . The P/E Ratio of AksharChem (India) Ltd changed from 15.3 on March 2021 to 36 on March 2025 . This represents a CAGR of 18.66% over 5 yearsThe P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of AksharChem (India) Ltd changed from ₹ 191.57 crore on March 2021 to ₹ 171.83 crore on March 2025 . This represents a CAGR of -2.15% over 5 yearsThe Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of AksharChem (India) Ltd for the Dec '25 is ₹ 80.42 crore as compare to the Sep '25 revenue of ₹ 91.03 crore. This represent the decline of -11.66% The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The ebitda of AksharChem (India) Ltd for the Dec '25 is ₹ 2.98 crore as compare to the Sep '25 ebitda of ₹ 4.08 crore. This represent the decline of -26.96% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The net profit of AksharChem (India) Ltd changed from ₹ 1.15 crore to ₹ -4.62 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The Dividend Payout of AksharChem (India) Ltd changed from 22.96 % on March 2021 to 12.63 % on March 2025 . This represents a CAGR of -11.27% over 5 yearsThe Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About AksharChem (India) Ltd

AksharChem (India) Limited (Formerly Known as Audichem (India) Limited) was promoted by Mrs. Paru M. Jaykrishna in 1989.
Company changed the name to AksharChem (India) Limited from Audichem (India) Limited effective on March 23, 2004.
The Company is headquartered in the chemical belt of Mehsana (Gujarat) with a total manufacturing capacity of 23,400 metric tonnes per annum (MTPA).
Presently, the Company is principally engaged in the business of manufacturing & export of Dyes Pigments and Precipitated Silica. The Company's product fall into two categories organic chemicals and inorganic chemicals, which further diversified into Vinyl Sulphone, H Acid, CPC Green in organic chemicals and Precipitated Silica in inorganic chemicals.
Out of which organic chemicals have multiple applications in textile, inks, plastics and paints industries and inorganic chemicals have applications in tyre, rubber, agrochemical and animal feed industries.

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

FAQs for the comparison of AksharChem (India) Ltd and Anlon Healthcare Ltd

Which company has a larger market capitalization, AksharChem (India) Ltd or Anlon Healthcare Ltd?

Market cap of AksharChem (India) Ltd is 147 Cr while Market cap of Anlon Healthcare Ltd is 644 Cr

What are the key factors driving the stock performance of AksharChem (India) Ltd and Anlon Healthcare Ltd?

The stock performance of AksharChem (India) Ltd and Anlon Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for AksharChem (India) Ltd and Anlon Healthcare Ltd?

As of March 23, 2026, the AksharChem (India) Ltd stock price is INR ₹183.05. On the other hand, Anlon Healthcare Ltd stock price is INR ₹121.35.

How do dividend payouts of AksharChem (India) Ltd and Anlon Healthcare Ltd compare?

To compare the dividend payouts of AksharChem (India) Ltd and Anlon Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.